NN

Netra Nilesh Kolte

Active Director Designated Partner DIN 08454339
DIN 08454339 First appointment May 2019 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Netra Nilesh Kolte

Data last updated:

Netra Nilesh Kolte is a Designated Partner at Pharmoneers Healthcare Llp (since 2019). The company operates in Healthcare.

DIN 08454339
Primary Designation Designated Partner
Industry Healthcare
First Appointment 17 May 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 May 20192019Active

Board colleagues of Netra Nilesh Kolte

Directorship timeline

Open interactive timeline →
Pharmoneers Healthcare Llp
Premium access

Shareholding and investment profile for Netra Nilesh Kolte

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Netra Nilesh Kolte

Netra Nilesh Kolte currently holds 1 directorship: Pharmoneers Healthcare Llp (Designated Partner, since 17 May 2019).

Netra Nilesh Kolte was first appointed on 17 May 2019 as Designated Partner at Pharmoneers Healthcare Llp.

The current boards of Netra Nilesh Kolte's companies include Raju Damu Jadhav (Pharmoneers Healthcare Llp), Roshan Vilas Kalbende (Pharmoneers Healthcare Llp), Sadashiv Pandurang Shinde (Pharmoneers Healthcare Llp), Samrudhi Subhash Bhoir (Pharmoneers Healthcare Llp), Tukaram Babaji Kavitakar (Pharmoneers Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available